$11.26 (-0.97%)

Volume: 1.069M

Closed: Feb 03, 2023

Hollow Logo Score: 1.066
Anavex Life Sciences Corp. Stock
$11.26 (-0.97%)

Volume: 1.069M

Closed: Feb 03, 2023

Score Hollow Logo 1.066
NASDAQ:AVXL

Anavex Life Sciences Corp. Stock Price (Quote)

$11.26 ( -0.97% ) Friday, 3rd Feb 2023

Range Low Price High Price Comment
30 days $9.46 $11.71 Friday, 3rd Feb 2023 AVXL stock ended at $11.26. This is 0.97% less than the trading day before Thursday, 2nd Feb 2023. During the day the stock fluctuated 4.89% from a day low at $11.05 to a day high of $11.59.
90 days $7.63 $15.24
52 weeks $7.13 $15.24

Historical Anavex Life Sciences Corp. prices

Date Open High Low Close Volume
2023-02-03 $11.11 $11.59 $11.05 $11.26 1 069 259
2023-02-02 $11.09 $11.71 $10.97 $11.37 1 430 566
2023-02-01 $10.89 $11.22 $10.57 $10.99 1 170 949
2023-01-31 $10.13 $10.89 $10.06 $10.87 1 369 166
2023-01-30 $10.74 $10.76 $9.84 $10.05 1 922 059
2023-01-27 $10.52 $10.69 $10.41 $10.56 601 500
2023-01-26 $10.91 $10.99 $10.39 $10.52 594 548
2023-01-25 $10.52 $10.83 $10.32 $10.79 871 783
2023-01-24 $10.38 $10.91 $10.22 $10.72 1 154 251
2023-01-23 $10.33 $10.58 $10.13 $10.47 970 684
2023-01-20 $10.22 $10.41 $9.98 $10.30 981 763
2023-01-19 $9.99 $10.24 $9.65 $10.10 1 116 600
2023-01-18 $10.56 $10.75 $10.06 $10.13 1 206 547
2023-01-17 $10.50 $10.63 $10.21 $10.46 1 621 981
2023-01-13 $11.05 $11.34 $10.15 $10.58 2 105 408
2023-01-12 $10.86 $11.24 $10.38 $11.21 1 923 905
2023-01-11 $10.39 $10.82 $10.10 $10.80 1 483 107
2023-01-10 $9.83 $10.39 $9.78 $10.39 1 170 341
2023-01-09 $10.14 $10.17 $9.57 $9.85 1 121 519
2023-01-06 $10.02 $10.20 $9.68 $10.00 1 543 800
2023-01-05 $9.91 $9.97 $9.46 $9.87 1 062 077
2023-01-04 $9.74 $10.09 $9.46 $9.97 1 351 582
2023-01-03 $9.89 $9.89 $9.32 $9.68 1 759 063
2022-12-30 $9.00 $9.26 $8.91 $9.26 1 080 798
2022-12-29 $8.29 $9.28 $8.20 $9.13 1 852 252
2022-12-28 $8.11 $8.34 $8.01 $8.19 1 007 153
2022-12-27 $8.45 $8.55 $8.13 $8.16 1 196 164
2022-12-23 $8.60 $8.69 $8.22 $8.45 850 312
2022-12-22 $8.60 $8.69 $8.28 $8.57 1 204 159
2022-12-21 $8.68 $8.86 $8.44 $8.61 1 171 623
2022-12-20 $8.47 $8.91 $8.36 $8.71 1 094 310
2022-12-19 $8.65 $8.69 $8.18 $8.51 1 634 836
2022-12-16 $8.27 $8.70 $8.19 $8.64 3 155 206
2022-12-15 $8.70 $8.80 $8.30 $8.35 1 537 386
2022-12-14 $8.68 $8.98 $8.50 $8.83 1 319 980
2022-12-13 $8.94 $9.05 $8.37 $8.74 1 780 898
2022-12-12 $7.75 $8.85 $7.73 $8.67 3 394 869
2022-12-09 $7.99 $8.07 $7.63 $7.65 2 292 232
2022-12-08 $8.50 $8.52 $7.95 $8.08 2 635 981
2022-12-07 $8.34 $9.10 $8.31 $8.49 2 737 453
2022-12-06 $9.21 $9.21 $8.34 $8.38 6 006 781
2022-12-05 $12.03 $12.11 $9.56 $9.58 8 403 482
2022-12-02 $12.57 $13.23 $10.66 $12.05 45 682 568
2022-12-01 $8.90 $9.57 $8.80 $8.87 2 157 524
2022-11-30 $8.96 $9.14 $8.29 $8.82 4 017 257
2022-11-29 $9.24 $9.46 $8.77 $8.94 2 155 419
2022-11-28 $12.46 $12.49 $8.87 $9.10 4 351 921
2022-11-25 $11.30 $11.95 $11.25 $11.89 778 695
2022-11-23 $11.72 $11.86 $11.09 $11.36 958 169
2022-11-22 $11.80 $11.80 $10.97 $11.42 1 052 751

Hot Stocks To Watch:

About Anavex Life Sciences Corp.

Anavex Life Sciences Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patients with Rett syndrome; Phase II clinical trial for the treatment of Parkinson's disease; and preclinica... AVXL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT